A New Perspective on the Management of Primary Immunodeficiencies: Evaluation of Arrhythmia and Cardiac Diseases
Cardiology · 2025
DOI: 10.1159/000543381 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiology, 2025. Verfasst von Mustafa Ilker Inan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology and Allergy, Gulhane Training and Research Hospital, Ankara, Turkey. Hauptthemen laut MEDLINE: Arrhythmias, Cardiac, Heart Diseases, Primary Immunodeficiency Diseases, Immunologic Deficiency Syndromes. Die Arbeit nennt 33 Literaturangaben.
Abstract (Originalsprache)
Introduction
Primary immunodeficiency diseases (PIDs) are a growing group of rarely seen diseases. Various clinical conditions like autoimmunity, lymphoproliferative/malignant diseases, chronic lung, and gastrointestinal system diseases have been identified which accompanies PIDs besides recurrent infections. However, there is a lack of information about accompanying cardiovascular diseases. We aimed to determine the frequency of cardiovascular diseases and arrhythmias in PID patients.
Methods
Forty-eight PID patients and 48 control group patients were included to this single-center, prospective controlled study. All patients underwent resting electrocardiogram, echocardiogram and 7-lead 24-h ambulatory electrocardiogram (Holter) monitoring assessed by an experienced cardiologist.
Results
Both supraventricular and ventricular extrasystoles were found to be statistically significantly higher in patient group in terms of frequency and sustained, non-sustained, and runs compared to control group. The median of total supraventricular extrasystoles was 8 (0–65) in patient group which was 0.5 (0–4.5) in control group (p < 0.001) while the median of total ventricular extrasystoles was 2 (0–45.5) and 0 (0–2) in two groups, respectively (p = 0.022). Eighteen patients (37.5%) had supraventricular and/or ventricular arrhythmias. The patient group had a statistically significantly higher systolic pulmonary artery pressure value compared to control group (20 [16–28] vs. 17.5 [15–25]; p = 0.036). We found 7 patients had 13 structural heart diseases including second degree or above valve pathologies in patient group whereas none of the control group patients had these diseases (p = 0.013).
Conclusion
With the positive findings of higher frequency and risk of arrhythmias and various structural heart diseases, we hope that our study will provide a new perspective on the management of PID patients, contributing positively to their survival and early prevention of cardiovascular comorbidities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Immunology and Allergy, Gulhane Training and Research Hospital, Ankara, Turkey.
- Department of Cardiology, Gulhane Training and Research Hospital, Ankara, Turkey.
Zitieren
APA
Inan, M. I., Inan, M. I., Akgul Balaban, Y., Yagci, A. F., Kartal, O., Bugan, B., Kalkan, F., Sonmez, E., Demirel, F., Selcuk, A., & Yesillik, S. (2025). A New Perspective on the Management of Primary Immunodeficiencies: Evaluation of Arrhythmia and Cardiac Diseases. Cardiology. https://doi.org/10.1159/000543381
Vancouver
Inan MI, Inan MI, Akgul Balaban Y, Yagci AF, Kartal O, Bugan B, et al. A New Perspective on the Management of Primary Immunodeficiencies: Evaluation of Arrhythmia and Cardiac Diseases. Cardiology. 2025. doi:10.1159/000543381
BibTeX
@article{Inan2025,
author = {Inan, Mustafa Ilker and Inan, Mustafa Ilker and Akgul Balaban, Yasemin and Yagci, Ahmet Faruk and Kartal, Ozgur and Bugan, Baris and Kalkan, Fikriye and Sonmez, Ezgi and Demirel, Fevzi and Selcuk, Ali and Yesillik, Sait},
title = {A New Perspective on the Management of Primary Immunodeficiencies: Evaluation of Arrhythmia and Cardiac Diseases},
journal = {Cardiology},
year = {2025},
doi = {10.1159/000543381}
}
EUVIMED